QI
CLDX icon

QS Investors’s Celldex Therapeutics CLDX Stock Holding History

QS Investors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,769
Closed -$77K – 1680
2018
Q4 		$77K Hold
25,769
– – ﹤0.01% 1384
2018
Q3 		$174K Hold
25,769
– – ﹤0.01% 1240
2018
Q2 		$195K Hold
25,769
– – ﹤0.01% 1223
2018
Q1 		$901K Sell
25,769
-1,609
-6% -$62.3K 0.01% 808
2017
Q4 		$1.17M Sell
27,378
-1,247
-4% -$53.4K 0.01% 763
2017
Q3 		$1.23M Sell
28,625
-624
-2% -$23.4K 0.01% 760
2017
Q2 		$1.08M Sell
29,249
-105
-0.4% -$4.64K 0.01% 763
2017
Q1 		$1.59M Hold
29,354
– – 0.01% 665
2016
Q4 		$1.56M Buy
29,354
+27,591
+1,565% +$1.57M 0.01% 673
2016
Q3 		$107K Buy
+1,763
New +$110K ﹤0.01% 1250
2016
Q1 		– Sell
-1
Closed -$1K – 1993
2015
Q4 		$1K Buy
+1
New +$218 ﹤0.01% 1583

Other funds holding CLDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return